Elmer Maurits

Leiden, ZH 2333CC, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Structure-Based Design of Pan-Selective Peptide Epoxyketones for the Three Human Immunoproteasome Active Sites.

Structure-Based Design of Pan-Selective Peptide Epoxyketones for the Three Human Immunoproteasome Active Sites.

Journal: Journal of medicinal chemistry

Published: January 08, 2026

Inhibitors of the 20S proteasome β5 subunit as potent and selective agents against Trichomonas vaginalis.

Inhibitors of the 20S proteasome β5 subunit as potent and selective agents against Trichomonas vaginalis.

Journal: Antimicrobial agents and chemotherapy

Published: November 11, 2025

Selective labelling of GBA2 in cells with fluorescent β-d-arabinofuranosyl cyclitol aziridines.

Selective labelling of GBA2 in cells with fluorescent β-d-arabinofuranosyl cyclitol aziridines.

Journal: Chemical science

Published: November 16, 2023

Title Not Found

Title Not Found

Journal: European journal of immunology

Published: June 16, 2023

High-dose carfilzomib achieves superior anti-tumor activity over low-dose and recaptures response in relapsed/refractory multiple myeloma resistant to lowdose carfilzomib by co-inhibiting the β2 and β1 subunits of the proteasome complex.

High-dose carfilzomib achieves superior anti-tumor activity over low-dose and recaptures response in relapsed/refractory multiple myeloma resistant to lowdose carfilzomib by co-inhibiting the β2 and β1 subunits of the proteasome complex.

Journal: Haematologica

Published: October 06, 2022

Immunoproteasome Activity in Chronic Lymphocytic Leukemia as a Target of the Immunoproteasome-Selective Inhibitors.

Immunoproteasome Activity in Chronic Lymphocytic Leukemia as a Target of the Immunoproteasome-Selective Inhibitors.

Journal: Cells

Published: January 27, 2022

High Immunoproteasome Activity and sXBP1 in Pediatric Precursor B-ALL Predicts Sensitivity towards Proteasome Inhibitors.

High Immunoproteasome Activity and sXBP1 in Pediatric Precursor B-ALL Predicts Sensitivity towards Proteasome Inhibitors.

Journal: Cells

Published: September 29, 2021

Synthetic methodology towards allylic trans-cyclooctene-ethers enables modification of carbohydrates: bioorthogonal manipulation of the lac repressor.

Synthetic methodology towards allylic trans-cyclooctene-ethers enables modification of carbohydrates: bioorthogonal manipulation of the lac repressor.

Journal: Chemical science

Published: June 07, 2021

Structure-Based Design of Fluorogenic Substrates Selective for Human Proteasome Subunits.

Structure-Based Design of Fluorogenic Substrates Selective for Human Proteasome Subunits.

Journal: Chembiochem : a European journal of chemical biology

Published: June 11, 2020

Fluorogenic Bifunctional trans-Cyclooctenes as Efficient Tools for Investigating Click-to-Release Kinetics.

Fluorogenic Bifunctional trans-Cyclooctenes as Efficient Tools for Investigating Click-to-Release Kinetics.

Journal: Chemistry (Weinheim an der Bergstrasse, Germany)

Published: December 02, 2019

Structure-Based Design of Inhibitors Selective for Human Proteasome β2c or β2i Subunits.

Structure-Based Design of Inhibitors Selective for Human Proteasome β2c or β2i Subunits.

Journal: Journal of medicinal chemistry

Published: January 19, 2019

Proteasome Inhibition in Multiple Myeloma: Head-to-Head Comparison of Currently Available Proteasome Inhibitors.

Proteasome Inhibition in Multiple Myeloma: Head-to-Head Comparison of Currently Available Proteasome Inhibitors.

Journal: Cell chemical biology

Published: August 28, 2018

Showing 1-12 of 17

Last Updated: 09/26/2026